Mission Statement, Vision, & Core Values of Paragon 28, Inc. (FNA)

Mission Statement, Vision, & Core Values of Paragon 28, Inc. (FNA)

US | Healthcare | Medical - Devices | NYSE

Paragon 28, Inc. (FNA) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Ever wondered what drives a company focused solely on foot and ankle orthopedics, especially when they're making waves in the medical device industry? What are the guiding principles behind Paragon 28's innovative solutions and their commitment to improving patient outcomes?

Let's dive into the core of Paragon 28, exploring their mission, vision, and values that underpin their success. With preliminary unaudited net revenue for 2024 expected to be in the range of $255.9 million to $256.2 million, reflecting a growth of approximately 18.2% to 18.4% compared to 2023, it's clear that these principles are more than just words on paper.

How do these elements translate into their daily operations and contribute to their growth and innovation in the foot and ankle market? Read on to find out!

Paragon 28, Inc. (FNA) An Overview of

Paragon 28, Inc. specializes in developing, manufacturing, and marketing orthopedic foot and ankle surgical solutions. Founded in 2010, the company offers an extensive range of products, including implants, surgical instruments, and disposable kits, designed to address various foot and ankle conditions such as fractures, bunions, and arthritis. As of April 2025, Paragon 28 continues to focus on innovation and expanding its product portfolio to meet the evolving needs of foot and ankle surgeons globally.

In the fiscal year 2024, Paragon 28 reported record revenue, driven significantly by the sales of its core product lines. The company has experienced substantial growth in both domestic and international markets. For a detailed analysis, check out Breaking Down Paragon 28, Inc. (FNA) Financial Health: Key Insights for Investors.

Paragon 28 stands out as a leader in the foot and ankle orthopedic industry due to its commitment to innovation, comprehensive product offerings, and focus on surgeon education and customer satisfaction. The company's success can be attributed to several factors:

  • Innovative Product Development: Paragon 28 continuously invests in research and development to create cutting-edge solutions that improve patient outcomes.
  • Extensive Product Portfolio: The company offers a broad range of products that address a wide variety of foot and ankle conditions.
  • Surgeon Education and Training: Paragon 28 provides extensive training and education programs for surgeons to ensure the proper use of its products and techniques.
  • Customer Focus: The company is committed to providing exceptional customer service and support to its surgeon customers.

To understand the reasons behind Paragon 28's success, delve deeper into the specifics of its mission, vision, and core values, which drive its strategic decisions and operational practices.

Paragon 28, Inc. (FNA) Mission Statement

Paragon 28, Inc., a medical device company exclusively focused on the foot and ankle orthopedic market, directs its efforts and upholds its values through a clearly defined mission statement. The mission statement is to continuously improve the outcomes and experiences of patients with foot and ankle conditions. Paragon 28, Inc. (FNA): History, Ownership, Mission, How It Works & Makes Money

The company's dedication extends beyond just developing products. It emphasizes a comprehensive approach to addressing foot and ankle problems, questioning existing procedures, and seeking ways to streamline and improve them. This involves considering how to make procedures more reproducible and reduce surgeon anxiety when dealing with complex cases.

Paragon 28 was established in 2010. The name 'Paragon 28' reflects the company's exclusive focus on the foot and ankle, with the '28' representing the number of bones in the foot. The company's initial product was the Monster® Screw System, followed by the Gorilla® Plating System.

As of December 31, 2024, Paragon 28 has a trailing 12-month revenue of $256 million. The preliminary unaudited net revenue for the full year 2024 is expected to be in the range of $255.9 to $256.2 million, representing reported growth of approximately 18.2% to 18.4% compared to the full year 2023.

Paragon 28's mission is supported by several core principles:

  • Creation and Innovation: Blending different surgical philosophies from various global thought leaders to develop biomechanically and clinically relevant surgical solutions.
  • A Focus on Service: Providing a customer service-based, dedicated, and highly trained distribution network to the foot and ankle market.
  • Efficient Practices: Meeting the needs of increasing pricing pressures and reimbursement while continuing to develop cutting-edge surgical implants.
  • Practical and Comprehensive Solutions: Creating complete surgeon-centric systems, specialty instruments, and next-generation implants to solve real-world issues faced by foot and ankle surgeons.
  • Research Motivated: Relentlessly working to advance the science behind foot and ankle surgery.

Paragon 28's Vision Statement is to strategically build a company around the core principles that drive innovation and quality - relentlessly working to advance the science behind foot and ankle surgery.

These values are also reflected in the company's efforts to maintain industry expertise, integrating diverse surgical philosophies, and continuously investing in research and development.

Paragon 28, Inc. (FNA) Vision Statement of

To fully understand Paragon 28, Inc.'s strategic direction as of April 2025, it's essential to examine its mission, vision, and core values. These elements provide a clear picture of the company’s goals, aspirations, and guiding principles. You may also find valuable insights in this related resource: Paragon 28, Inc. (FNA): History, Ownership, Mission, How It Works & Makes Money

Paragon 28, Inc. focuses on the foot and ankle orthopedic market. Their vision reflects a commitment to innovation and improving patient outcomes in this specialized field.

Mission Statement

While specific current mission statements are difficult to find, mission statements generally outline a company's purpose and primary objectives. Based on Paragon 28's activities, a mission statement might read as follows:

To be the leading provider of innovative solutions for foot and ankle surgeons, improving patient outcomes through cutting-edge implants, instrumentation, and surgical techniques.

  • Focuses on being a leading provider.
  • Highlights innovation as a key element.
  • Emphasizes improving patient outcomes.

Vision Statement

As of April 2025, the specific and officially declared vision statement for Paragon 28, Inc. is not readily available in public sources. However, we can infer potential elements of their vision based on their market activities and strategic goals. A vision statement usually describes the desired future state of the company.

Here's a possible interpretation of what their vision statement might encompass:

To transform foot and ankle care worldwide by pioneering innovative technologies and empowering surgeons to achieve superior patient outcomes.

Key components of this potential vision statement include:

  • Transformation of Foot and Ankle Care: This suggests a broad ambition to revolutionize the treatment landscape.
  • Pioneering Innovative Technologies: This emphasizes the company's commitment to being at the forefront of technological advancements.
  • Empowering Surgeons: This indicates a focus on providing surgeons with the tools and support they need to excel.
  • Achieving Superior Patient Outcomes: This underscores the ultimate goal of improving the quality of life for patients.

Core Values

Core values define the principles that guide a company's actions and culture. While Paragon 28's exact core values are not explicitly listed, we can deduce potential values based on their business practices and industry presence.

Possible core values could include:

  • Innovation: A dedication to continuously developing new and improved products and techniques.
  • Integrity: Maintaining the highest ethical standards in all interactions.
  • Collaboration: Working closely with surgeons and other healthcare professionals to achieve shared goals.
  • Quality: Committing to excellence in design, manufacturing, and customer service.
  • Patient-Focus: Prioritizing the well-being and outcomes of patients above all else.

These values likely influence the company's decisions and shape its relationships with employees, customers, and stakeholders.

Paragon 28, Inc. (FNA) Core Values of

While specific details regarding Paragon 28's mission statement, vision, and core values are not explicitly available in the provided search results, we can infer their likely focus based on the company's operations and industry context. Paragon 28, Inc., specializes in foot and ankle orthopedic solutions. Their core values likely revolve around innovation, quality, patient-centricity, and integrity.

Given the absence of explicit statements, the following sections provide a likely interpretation of Paragon 28's core values, supported by the company's actions and industry norms.

Innovation

Innovation is likely a central value for Paragon 28, driving the development of advanced orthopedic solutions. This commitment is evident in their focus on addressing complex foot and ankle conditions with novel surgical implants and techniques.

  • Product Development: Investment in research and development to create cutting-edge products. For example, the company invests a significant portion of its revenue in R&D to develop, and enhance its product offerings. In 2024, Paragon 28's R&D expenses were $23.7 million, compared to $18.9 million in 2023.
  • Technological Advancement: Embracing new technologies to improve surgical outcomes and patient recovery.

Quality

Maintaining high standards of quality in both products and services is crucial in the medical device industry. Paragon 28 likely emphasizes rigorous testing and adherence to regulatory standards to ensure the safety and effectiveness of its products.

  • Regulatory Compliance: Ensuring all products meet or exceed FDA requirements and other international standards.
  • Manufacturing Excellence: Implementing stringent quality control processes throughout the manufacturing process.

Patient-Centricity

A commitment to improving patient outcomes is often a core value for companies in the healthcare sector. Paragon 28 likely prioritizes understanding the needs of patients and surgeons to develop solutions that enhance the quality of care.

  • Surgeon Collaboration: Working closely with surgeons to gather feedback and develop solutions that meet their specific needs.
  • Educational Programs: Providing training and resources to surgeons to ensure the proper use of their products and improve patient outcomes.

Integrity

Operating with honesty, transparency, and ethical conduct is essential for building trust with customers, partners, and stakeholders. Paragon 28 likely emphasizes integrity in all aspects of its business, from product development to sales and marketing.

  • Ethical Business Practices: Adhering to a strict code of conduct and promoting ethical behavior throughout the organization.
  • Transparency: Communicating openly and honestly with stakeholders about product performance and potential risks.

For more insights into Paragon 28, Inc., consider reading: Exploring Paragon 28, Inc. (FNA) Investor Profile: Who’s Buying and Why?

DCF model

Paragon 28, Inc. (FNA) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.